Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 
 

 
Prescribed Drug Estimates: 2003
Table 1.2 Top Prescribed Drugs by Total Purchases, 2003
Prescribed
drug name
Total purchases
ranking
Total
purchases
Total number of
persons with purchases

Lipitor
1
78,560,970

13,073,351

Synthroid
2
60,975,520

8,941,789

Atenolol
3
43,024,276

7,254,530

Hydrochlorothiazide
4
42,448,550

7,926,903

Zocor
5
41,806,656

7,463,572

Lisinopril
6
39,339,948

6,714,888

Albuterol
7
35,963,676

11,141,969

Furosemide
8
34,948,042

5,855,786

Norvasc
9
34,846,009

5,930,562

Lancets
10
32,612,686

7,808,163

Standard Errors for Table 1.2: Top Prescribed Drugs by Total Purchases, 2003

Prescribed
drug name
Total
purchases
Total number of
persons with purchases

Lipitor
4,332,454.17 563,839.12
Synthroid
3,173,762.08 402,639.13
Atenolol
2,226,326.70 358,064.18
Hydrochlorothiazide
1,928,945.78 325,439.00
Zocor
2,666,704.52 381,885.59
Lisinopril
2,896,799.31 379,427.06
Albuterol
1,966,224.57 444,896.88
Furosemide
2,247,732.24 306,644.73
Norvasc
2,097,863.45 303,181.07
Lancets
1,842,518.23 348,357.77

 


MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov